News search

    E.g., 26/04/2024
    E.g., 26/04/2024
    Valentín Fuster
    Research
    26 Aug 2022
    NEJM: The polypill reduces cardiovascular mortality by 33% in patients treated after myocardial infarction

    The results of the SECURE trial, coordinated by CNIC were presented in a Hot Line session at the European Society of Cardiology meeting (ESC 2022) in Barcelona and published at the NEJM

    Grupo de Andrés Hidalgo
    About the CNIC
    22 Jul 2022
    Andrés Hidalgo obtains the 18th Annual Health Sciences Awardf from the Caja Rural Granada Foundation
    Andrés Hidalgo
    About the CNIC
    6 Jul 2022
    Dr. Andrés Hidalgo elected a member of the European Molecular Biology Organization – EMBO

    Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences
    Dr. Cristóbal Belda se convirtió en el nuevo Director del Instituto de Salud Carlos III.
    Research
    11 May 2022
    Cristóbal Belda, Director del ISCIII: “PERTE represents an opportunity to help our country”
    About the CNIC
    27 Jan 2022
    Dr. Valentin Fuster Honored by Thailand Royalty for Outstanding Medical Contributions

    Five of the past award winners of this award subsequently received the Nobel Prize
    About the CNIC
    26 Jan 2022
    Dr. Valentín Fuster, awarded for his social commitment as a disseminator and promoter of healty habits among the population
    Miguel Palomino Segura, Georgiana Crainiciuc, Jon Sicilia y Andrés Hidalgo
    Research
    5 Jan 2022
    Nature: CNIC scientists discover a cell behavior pattern that predicts cardiovascular disease

    Scientists at the CNIC have developed a simple model for studying the behavior of immune cells in live animals and have identified a harmful cell behavior pattern associated with cardiovascular disease
    About the CNIC
    9 Jun 2021
    Article by Dr Sabio's group receives the Antoni Esteve Foundation Research Award

    The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide
    Scheme of a cMyBP-C region in which mutations cause amino-acid changes that alter the mechanical properties of the protein. The positions of the affected amino acids are shown in red.
    Research
    7 Jun 2021
    ACS Nano: CNIC scientists describe a possible disease-causing mechanism in hypertrophic cardiomyopathy

    A team led by Dr. Jorge Alegre-Cebollada has shown, for the first time, an association between hypertrophic cardiomyopathy and mechanical alterations to a component of the contractile machinery of the heart
    Dr. Miguel Torres
    About the CNIC
    10 May 2021
    Dr. Miguel Torres appointed Associate Editor of Science Advances

    Dr. Torres is a member of the European Molecular Biology Organization (EMBO). Dr. Miguel Torres’s scientific research focuses on the regulation of embryonic development and the formation and regeneration of organs.